Cargando…

Clinical Pharmacogenetics of Angiotensin II Receptor Blockers in Iraq

BACKGROUND: Clinical pharmacogenetics is a rapidly growing field that focuses on the study of genetic variations and their impact on drug metabolism, efficacy, and safety. Angiotensin II receptor blockers (ARBs) are commonly used to treat hypertension in Iraq but not all patients respond equally to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Al-Hussaniy, Hany A., Hassan, Alaa F., Oraibi, Amjad I., Al-Juhaishi, Atheer M. R., Naji, Fatima A., Al-Tameemi, Zahraa S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2023
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10496849/ https://www.ncbi.nlm.nih.gov/pubmed/37705854 http://dx.doi.org/10.4103/jpbs.jpbs_313_23

Ejemplares similares

Chemotherapy-induced cardiotoxicity: a new perspective on the role of Digoxin, ATG7 activators, Resveratrol, and herbal drugs
por: Al-hussaniy, Hany Akeel, et al.
Publicado: (2023)

Non-alcoholic fatty liver disease: relation to juvenile obesity, lipid profile, and hepatic enzymes
por: Altalebi, Raghid Reyadh, et al.
Publicado: (2023)

Intraoperative angioedema induced by angiotensin II receptor blocker: a case report
por: Alhowary, Ala”a, et al.
Publicado: (2018)

Leptin hormone and its effectiveness in reproduction, metabolism, immunity, diabetes, hopes and ambitions
por: Al-hussaniy, Hany Akeel, et al.
Publicado: (2021)

Neurosurgery in Iraq at the Time of Corona
por: Hoz, Samer S., et al.
Publicado: (2020)

Alwitri: The father of modern neurosurgery in Iraq
por: Al-Khafaji, Abd Al-Ameer J., et al.
Publicado: (2021)

The Effect of MicroRNA-409-3p for Treatment and Response to Tumor Proliferation of Lung Cancer Cell Lines (In Vitro)
por: Al-Hussaniy, Hany Akeel
Publicado: (2022)

Receptor Interactions of Angiotensin II and Angiotensin Receptor Blockers—Relevance to COVID-19
por: Moore, Graham J., et al.
Publicado: (2021)

Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Blockers With Severity of COVID-19: A Multicenter, Prospective Study
por: Hakeam, Hakeam A., et al.
Publicado: (2020)

Angiotensin II Receptor Blockers and Arrhythmias in Ventricular Hypertrophy
por: Salama, Guy
Publicado: (2022)

Fracture Risk and Use of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers
por: Holloway-Kew, Kara L., et al.
Publicado: (2022)

The Fetal Safety of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers
por: Moretti, Myla E., et al.
Publicado: (2012)

Pneumonia Risk and Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers
por: Liu, Chia-Lin, et al.
Publicado: (2013)

Effect of angiotensin converting enzyme inhibitor and angiotensin II receptor blocker on the patients with sepsis
por: Lee, Hyun Woo, et al.
Publicado: (2021)

Summertime dosage-dependent hypersensitivity to an angiotensin II receptor blocker
por: Forsdyke, Donald R
Publicado: (2015)

Following the footprints of pioneers on neurosurgery in Iraq: Abdul Hadi Al-Khalili
por: Al-Sharshahi, Zahraa F., et al.
Publicado: (2021)

Molecular detection of Spirochetes and Borrelia burgdorferi in stray dogs of Nineveh province, Iraq
por: Ajaj, Eva Ayser, et al.
Publicado: (2023)

Seroprevalence of canine hepatitis in stray dogs in Nineveh Province, Iraq
por: Al-Jumaa, Zahraa Mustafa, et al.
Publicado: (2020)

Neurosurgery training in war-torn countries: A perspective from Iraq and Syria
por: Hoz, Samer S., et al.
Publicado: (2020)

Adherence and optimization of angiotensin converting enzyme inhibitor/angiotensin II receptors blockers and beta‐blockers in patients hospitalized for acute heart failure
por: Carubelli, Valentina, et al.
Publicado: (2021)

Onset of Hyperkalemia following the Administration of Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker
por: Jun, Hye-Ran, et al.
Publicado: (2021)

Differential Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on COVID-19
por: Su, Lianjiu, et al.
Publicado: (2021)

Usage of Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker in Hypertension Intracerebral Hemorrhage
por: Zhang, Chao, et al.
Publicado: (2021)

Molecular docking, molecular dynamics, and in vitro studies reveal the potential of angiotensin II receptor blockers to inhibit the COVID-19 main protease
por: Alnajjar, Radwan, et al.
Publicado: (2020)

Role of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in cryoballoon ablation outcomes for paroxysmal atrial fibrillation
por: Al-Seykal, Ibragim, et al.
Publicado: (2022)

Genotyping of Cytomegalovirus from Symptomatic Infected Neonates in Iraq
por: Alwan, Sevan N., et al.
Publicado: (2019)

Visit-to-Visit Variability and Seasonal Variation in Blood Pressure With Single-Pill Fixed-Dose Combinations of Angiotensin II Receptor Blocker/Calcium Channel Blocker and Angiotensin II Receptor Blocker/Diuretic in Hypertensive Patients
por: Shiga, Yuhei, et al.
Publicado: (2015)

Angiotensin-Converting Enzyme (ACE) Inhibitors and Angiotensin Receptor Blockers (ARB) Are Protective Against ICU Admission and Mortality for Patients With COVID-19 Disease
por: ElAbd, Rawan, et al.
Publicado: (2021)

PubMed-indexed neurosurgical research productivity of Iraq-based neurosurgeons
por: Hoz, Samer S., et al.
Publicado: (2021)

Clinical Profile of Eprosartan: A Different Angiotensin II Receptor Blocker
por: Blankestijn, P. J, et al.
Publicado: (2008)

Angiotensin II receptor blockers in the prevention of complications from atrial fibrillation
por: Naccarelli, Gerald V, et al.
Publicado: (2009)

Angiotensin receptor blockers in heart failure after the ELITE II trial
por: Willenheimer, Ronnie
Publicado: (2000)

Angiotensin II receptor blockers induce autophagy in prostate cancer cells
por: Woo, Yunseo, et al.
Publicado: (2017)

Angiotensin receptor blocker add-on therapy in portal hypertension: To use angiotensin receptor blocker or not to use, that is the question
por: Lee, Hyun Woong
Publicado: (2014)

Sex Differences in the Effectiveness of Angiotensin‐Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Sacubitril–Valsartan for the Treatment of Heart Failure
por: Sohani, Zahra N., et al.
Publicado: (2023)

Combination therapy of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in chronic kidney disease
por: Vasavada, Nina, et al.
Publicado: (2009)

Angiotensin‐Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Outcomes in Patients Hospitalized for COVID‐19
por: Pan, Michael, et al.
Publicado: (2021)

Student evaluation of medical school curriculum transformation in Iraq
por: Jawad, Huda Noori, et al.
Publicado: (2020)

Angiotensin receptor blockers and COVID-19
por: Saavedra, Juan M.
Publicado: (2020)

Angiotensin receptor blocker neprilysin inhibitors
por: Usuda, Daisuke, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8s2srfsg47h8uqhaf15qdtbeo2